Drug Development also needs a “blueprint”

Before building a particular structure, we first get a bird's eye view and a blueprint.
Similarly, in the development of new drugs, the target characteristics of the drug must be determined, and a strategy is required
to evaluate which candidates are most likely to achieve this. In particular, the process of evaluating candidates should be conducted
simultaneously and as much as possible in the right order. This is “efficiency” and it is the optimal way to maximize the value of
new drugs.

Seamless Pathway of Candidate Evaluation

AIMS BioScience suggests 3 major components for candidate evaluation process

• 01 Types and orders of
  studies required to
  secure proper evidence
• 02 Expected study conduct
  schedule and
  timeline
• 03 Best available
  methodology and
  specific study design

Overall Evaluation Plan Example